`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`
`1:22-cv-23
`Civil Action No. __1:22-cv-23______________
`
`)
`)
`)
`)
`
`))
`
`))
`
`))
`
`)
`)
`)
`)
`
`))
`
`)
`
`))
`
`))
`
`)
`)
`)
`)
`
`))
`
`_________________________________
`_________________________________
`_________________________________
`_________________________________
`_________________________________,
`
`Plaintiff(s),
`
`v.
`
`_________________________________
`_________________________________
`_________________________________
`_________________________________
`_________________________________,
`
`Defendant(s)/
`Third-Party Plaintiff(s),
`
`v.
`
`_________________________________
`_________________________________
`_________________________________
`_________________________________
`_________________________________,
`
`)
`Third-Party Defendant(s).
`____________________________________)
`
`DISCLOSURE STATEMENT PURSUANT TO Fed. R. Civ. P. 7.1
`(Civil Action)
`
`Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ____________________,
` (type of party)
`who is ________________________________________, makes the following disclosure:
`(name of party)
`
`Page 1 of 2
`
`NOVO NORDISK INC. and NOVO
`NORDISK A/S
`
`MYLAN PHARMACEUTICALS INC.
`
`Plaintiffs
`
`Novo Nordisk A/S and Novo Nordisk Inc.
`
`
`
`Case 1:22-cv-00023-JPB Document 5 Filed 03/18/22 Page 2 of 2 PageID #: 458
`
`9 YES
`
` 9 NO
`
`2.
`
`If the answer to Number 1 is “yes,” list below any parent corporation or state that there
`is no such corporation:
`
`________________________________________________________________________
`
`________________________________________________________________________
`
`________________________________________________________________________
`
`
`
`3.
`
`If the answer to Number 1 is “yes,” list below any publically-held corporation that owns
`10% or more of the party’s stock or state that there is no such corporation:
`________________________________________________________________________
`________________________________________________________________________
`________________________________________________________________________
`________________________________________________________________________
`
`The undersigned party understands that under Rule 7.1 of the Federal Rules of Civil
`Procedure, it will promptly file a supplemental statement upon any change in the information that
`this statement requires.
`
`Date: ___________________
`
`__________________________________
`Signature of Counsel for Party
`
`Page 2 of 2
`
`1. Is the party a non-governmental corporate party?
`
`4
`
`Novo Nordisk A/S ("NNAS") is a publicly traded Danish corporation. NNAS's corporate parent is
`Novo A/S.
`
`Novo Nordisk Inc. is a privately held corporation wholly owned by Novo Nordisk US Holdings,
`Inc. Novo Nordisk US Holdings, Inc. is a privately held corporation wholly owned by NNAS.
`
`No publicly held company owns 10% or more of the stock of NNAS or Novo Nordisk Inc.
`
`March 18, 2022
`
`/s/ James F. Companion
`
`